Save your place

Sign in to WhoBought

Please try again later.

Stanley Druckenmiller Portfolio

Stanley Druckenmiller is closely associated with Duquesne Family Office.

Duquesne Family Office LLC Holdings · Q1 2026

Disclosed value
$2.9B
Holdings
65
Top sector
Healthcare
Filed
May 15, 2026
Performance
YTD
+14.8%
+5.8% vs S&P 500
1Y
+47.2%
+29.0% vs S&P 500
3Y
+214.2%
+149.9% vs S&P 500

Duquesne Family Office LLC Holdings · 65

Q1 2026 · Showing 15 positions from the selected holding view.

Estimated gain compares the quarter-end mark with a running share-weighted mean of covered-snapshot and add-quarter mean prices. Holdings with incomplete basis or price coverage are excluded.

Stock % Avg. buy price Estimated gain Quarter-end price Last transaction
SCommunication EquipmentEchoStar Corporation (SATS) 0.2%
Avg. buy price $45.28 Estimated gain+158.5%Quarter-end price $117.07 Last transaction New· Q3 2025Opened a new position
S 0.2% $45.28 +158.5% $117.07 New· Q3 2025Opened a new position
IMedical - PharmaceuticalsInsmed Incorporated (INSM) 6.4%
Avg. buy price $78.34 Estimated gain+108.7%Quarter-end price $163.52 Last transaction Reduced· Q1 2026Sold 22.1% of shares
I 6.4% $78.34 +108.7% $163.52 Reduced· Q1 2026Sold 22.1% of shares
DHardware, Equipment & PartsDaktronics, Inc. (DAKT) 0.4%
Avg. buy price $9.90 Estimated gain+97.4%Quarter-end price $19.55 Last transaction Reduced· Q1 2026Sold 34.0% of shares
D 0.4% $9.90 +97.4% $19.55 Reduced· Q1 2026Sold 34.0% of shares
NMedical - Diagnostics & ResearchNatera, Inc. (NTRA) 20.9%
Avg. buy price $111.63 Estimated gain+79.1%Quarter-end price $199.99 Last transaction Added· Q1 2026Increased shares by 22.0%
N 20.9% $111.63 +79.1% $199.99 Added· Q1 2026Increased shares by 22.0%
T 5.7% $190.50 +77.4% $337.95 Reduced· Q1 2026Sold 8.8% of shares
T 2.4% $17.86 +68.7% $30.12 Reduced· Q1 2026Sold 59.5% of shares
AAluminumAlcoa Corporation (AA) 3.4%
Avg. buy price $42.52 Estimated gain+56.0%Quarter-end price $66.33 Last transaction Added· Q1 2026Increased shares by 8.5%
A 3.4% $42.52 +56.0% $66.33 Added· Q1 2026Increased shares by 8.5%
W 0.8% $177.17 +41.1% $249.91 Reduced· Q1 2026Sold 68.4% of shares
L 0.4% $59.30 +35.9% $80.57 New· Q1 2026Opened a new position
L 1.0% $71.19 +30.3% $92.76 Reduced· Q1 2026Sold 65.1% of shares
BElectrical Equipment & PartsBloom Energy Corporation (BE) 0.6%
Avg. buy price $105.09 Estimated gain+28.9%Quarter-end price $135.49 Last transaction Reduced· Q1 2026Sold 81.6% of shares
B 0.6% $105.09 +28.9% $135.49 Reduced· Q1 2026Sold 81.6% of shares
LCommunication EquipmentLumentum Holdings Inc. (LITE) 0.2%
Avg. buy price $551.10 Estimated gain+27.5%Quarter-end price $702.76 Last transaction New· Q1 2026Opened a new position
L 0.2% $551.10 +27.5% $702.76 New· Q1 2026Opened a new position
Avg. buy price $135.75 Estimated gain+26.7%Quarter-end price $172.06 Last transaction Added· Q1 2026Increased shares by 0.8%
S 0.7% $135.75 +26.7% $172.06 Added· Q1 2026Increased shares by 0.8%
A 0.5% $121.40 +24.6% $151.28 New· Q1 2026Opened a new position
WChemicals - SpecialtyWestlake Corporation (WLK) 0.1%
Avg. buy price $96.97 Estimated gain+20.5%Quarter-end price $116.82 Last transaction New· Q1 2026Opened a new position
W 0.1% $96.97 +20.5% $116.82 New· Q1 2026Opened a new position
Data through Q1 2026 · filed May 15, 2026
15 of 25

Biggest position changes

In Q1 2026: 30 new, 12 added, 18 reduced, 19 exited.
Largest disclosed changes in Q1 2026, ranked by estimated dollar change using the quarter's average market price.
Reduced or exitedBought or added
A Amazon.com, Inc. (AMZN) −$153M G Alphabet Inc. (GOOGL) Exited−$121M T Teva Pharmaceutical Industries Limited (TEVA) −$113M E Entegris, Inc. (ENTG) Exited−$100M B Bloom Energy Corporation (BE) −$89M M MercadoLibre, Inc. (MELI) −$86M C Cogent Biosciences, Inc. (COGT) Exited−$82M C Coupang, Inc. (CPNG) −$80M N Natera, Inc. (NTRA) +$119M A Broadcom Inc. (AVGO) New+$64M C Caris Life Sciences, Inc. (CAI) New+$41M R Revolution Medicines, Inc. (RVMD) New+$32M H Humana Inc. (HUM) New+$28M N Nuvation Bio Inc. (NUVB) New+$25M T Twilio Inc. (TWLO) New+$22M S Sandisk Corporation (SNDK) New+$22M
Other share changes without a dollar estimate, ranked by size.
Reduced or exitedBought or added
Stubhub Hldgs Inc −939K
Restaurant Brands Intl Inc −755K
Figure Technology Solutio −389K
W Woodward, Inc. (WWD) −380K W Wolfspeed Inc. (WOLF) Exited−187K
iShares Inc −116K
Crh PLC −97K
C Cidara Therapeutics, Inc. (CDTX) Exited−49K Y YPF Sociedad Anónima (YPF) +2.6M S STMicroelectronics N.V. (STM) +1.8M O Olema Pharmaceuticals, Inc. (OLMA) New+987K
Jbs N.V. New+656K
iShares S&p Gsci Commodity- New+643K
T BBB Foods Inc. (TBBB) +434K
Global X Fds New+387K
Dbv Technologies S A New+383K

Portfolio composition

Largest holdings in Q1 2026, sized by their share of the disclosed portfolio. This shows what is owned, not what changed.

Natera, Inc. (NTRA): 20.9%Insmed Incorporated (INSM): 6.4%Taiwan Semiconductor Manufacturing Company Limited (TSM): 5.7%Alcoa Corporation (AA): 3.4%Teva Pharmaceutical Industries Limited (TEVA): 2.4%Other holdings: 61.2%
Show more

Portfolio over time

Each band is a top holding's share of the disclosed portfolio, quarter by quarter; the rest is grouped as other.
0%50%100%202120222023202420252026
Natera, Inc. (NTRA)Insmed Incorporated (INSM)Taiwan Semiconductor Manufacturing Company Limited (TSM)YPF Sociedad Anónima (YPF)BBB Foods Inc. (TBBB)Alcoa Corporation (AA)Other holdings

Investors with similar portfolios

About Stanley Druckenmiller and Duquesne Family Office LLC

Stanley Druckenmiller is closely associated with Duquesne Family Office. This page shows Duquesne's quarterly Form 13F report of certain United States listed long positions, not Druckenmiller's personal account or the family office's complete portfolio. Cash, short positions, private assets, many derivatives, and some foreign securities may be absent.

SEC filing history for Duquesne Family Office LLC

Stanley Druckenmiller FAQ

Profile refreshed July 20, 2026

What stocks does Stanley Druckenmiller own?

As of the Q1 2026 filing, Stanley Druckenmiller's largest disclosed holdings are Natera, Inc. (NTRA), Insmed Incorporated (INSM), Taiwan Semiconductor Manufacturing Company Limited (TSM). The table shows 15 of 65 positions by default, with an exact-count control for the remaining rows. Disclosed shares and values remain visible even when a separate market-price estimate is unavailable.

What did Stanley Druckenmiller buy last quarter?

The biggest disclosed buys in Q1 2026 were Natera, Inc. (NTRA), Broadcom Inc. (AVGO), Caris Life Sciences, Inc. (CAI), based on the Duquesne Family Office LLC 13F filing. New positions are marked "new" in the table above.

What did Stanley Druckenmiller sell last quarter?

The biggest reductions in Q1 2026 were Amazon.com, Inc. (AMZN), Teva Pharmaceutical Industries Limited (TEVA), Bloom Energy Corporation (BE). The filing comparison contains 19 full exits, summarized in the activity view above.

How big is Stanley Druckenmiller's portfolio?

The latest 13F discloses $2.9B across 65 positions in Q1 2026. 13F filings cover US-listed long positions only; cash and short positions are not disclosed.

How up to date is this?

Funds file 13Fs up to 45 days after each quarter ends, so this portfolio reflects Q1 2026, the latest disclosed quarter. The filing date is shown with every table.

Where does the Duquesne Family Office LLC portfolio data come from?

Non-rejected, non-superseded SEC Form 13F filings for Duquesne Family Office LLC provide the Q1 2026 holdings, disclosed values, and filing date shown here. WhoBought prefers filings whose value units validate and labels a sparse filing when validation is unavailable. Industry labels come from the local company classification record.

How is performance calculated?

Performance uses daily closing prices for holdings with available market-price history. It covers the priced share of disclosed value (67%); holdings without sufficient price history are excluded from the calculation.

Who is Stanley Druckenmiller?

Stanley Druckenmiller is an American investor who founded Duquesne Capital in 1981 and later became the lead portfolio manager for George Soros's Quantum Fund.

How did Druckenmiller enter investing?

After studying English and economics at Bowdoin, he left an economics PhD program to become an oil analyst at Pittsburgh National Bank. He founded Duquesne a few years later.

What was Druckenmiller's role in Black Wednesday?

Druckenmiller and George Soros took a large short position against the British pound in 1992 after concluding that the Bank of England could not sustain its defense of the currency.

Does Stanley Druckenmiller still run a hedge fund for outside clients?

No. He returned outside investors' money and closed Duquesne Capital in 2010. This page instead follows the later Duquesne Family Office filing.

What was Duquesne Capital's historical record?

Wikipedia reports an average annual return of about 30 percent with no money-losing year during the fund's run. That historical figure is separate from the current family-office holdings shown here.

What is Druckenmiller's investment style?

He is a top-down investor who has combined long and short stock positions with leverage, futures, and currency trades. That makes a stock-only 13F an incomplete picture of his approach.

Is this Druckenmiller's personal portfolio or net worth?

No. It is the Duquesne Family Office 13F filing. It does not calculate his personal wealth or disclose every asset held by the family office.

Can a reader reproduce Druckenmiller's strategy from the 13F?

No. The filing can reveal selected long equity positions, but it leaves out the shorts, currencies, futures, leverage, and timing decisions central to his style.